Differential involvement of reactive oxygen species in apoptosis caused by the inhibition of protein phosphatase 2A in Jurkat and CCRF-CEM human T-leukemia cells

Experimental and Molecular Pathology

Volumn 83, Issue 3, 2007, Pages 347-356

  Boudreau, Robert T M ^a   Conrad, David M ^a   Hoskin, David W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Apoptosis; Okadaic acid; Protein phosphatase 2A; Reactive oxygen species; T leukemia

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CALYCULIN A; CASPASE 3; DNA FRAGMENT; GLUTATHIONE; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; REACTIVE OXYGEN METABOLITE; TAUTOMYCIN;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; T CELL LEUKEMIA;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CASPASE 3; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; JURKAT CELLS; LEUKEMIA; LEUKEMIA, T-CELL; MEMBRANE POTENTIALS; OKADAIC ACID; PROTEIN PHOSPHATASE 2; REACTIVE OXYGEN SPECIES;

EID: 36048980916     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2007.09.003     Document Type: Article

References (47)

1. Benhar M., Dalyot I., Engelberg D., and Levitzki A. Enhanced ROS production in oncogenetically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol. Cell. Biol. 21 (2001) 6913-6926
2. Bialojan C., and Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem. J. 256 (1988) 283-290
3. Bøe R., Gjertsen B.T., Vintermyr O.K., Houge G., Lanotte M., and Døskeland S.O. The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. J. Exp. Med. 195 (1991) 237-246
4. Brar S.S., Corbin Z., Kennedy T.P., Hemendinger R., Thornton L., Bommarius B., Arnold R.S., Whorton A.R., Sturrock A.B., Huecksteadt T.P., Quinn M.T., Krenitsky K., Ardie K.G., Lambeth J.D., and Hoidal J.R. NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am. J. Physiol., Cell Physiol. 285 (2003) C353-C369
5. Budihardjo I., Oliver H., Lutter M., Luo X., and Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15 (1999) 269-290
6. Cai J., and Jones D.P. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J. Biol. Chem. 273 (1998) 11401-11404
7. Carmody R.J., and Cotter T.G. Signalling apoptosis: a radical approach. Redox Rep. 6 (2001) 77-90
8. Chatfield K., and Eastman A. Inhibitors of protein phosphatases 1 and 2A differentially prevent intrinsic and extrinsic apoptosis pathways. Biochem. Biophys. Res. Commun. 323 (2004) 1313-1320
9. Chou D.M., Petersen P., Walter J.C., and Walter G. Protein phosphatase 2A regulates binding of Cdc45 to the prereplication complex. J. Biol. Chem. 277 (2002) 40520-40527
10. Deng X., Ito T., Carr B., Mumby M., and May Jr. W.S. Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A. J. Biol. Chem. 273 (1998) 34157-34163
11. Favre B., Turowski P., and Hemmings B.A. Differential inhibition and posttranslational modification of protein phosphatases 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J. Biol. Chem. 272 (1997) 13856-13863
12. Fernandez J.J., Candenas M.L., Souto M.L., Trujillo M.M., and Norte M. Okadaic acid, useful tool for studying cellular processes. Curr. Med. Chem. 9 (2002) 229-262
13. Fleury C., Mignotte B., and Vayssière J.-L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84 (2002) 131-141
14. 2 by peroxisomes. Free Radic. Biol. Med. 42 (2007) 1119-1129
15. Garcia A., Cayla X., Guergnon J., Dessauge F., Hospital V., Rebollo M.P., Fleischer A., and Rebollo A. Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis. Biochimie 85 (2003) 721-726
16. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am. J. Med. 91 (1991) 14S-22S
17. Härmälä-Braskén A.S., Mikhailov A., Söderström T.S., Meinander A., Holmström T.H., Damuni Z., and Eriksson J.E. Type-2A protein phosphatase activity is required to maintain death receptor responsiveness. Oncogene 22 (2003) 7677-7686
18. Higuchi Y. Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis. J. Cell. Mol. Med. 8 (2004) 455-464
19. Inomata M., Saijo N., Kawashima K., Kaneko A., Fujiwara Y., Kunikane H., and Tanaka Y. Induction of apoptosis in cultured retinoblastoma cells by the protein phosphatase inhibitor, okadaic acid. J. Cancer Res. Clin. Oncol. 121 (1995) 729-738
20. Janssens V., and Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353 (2001) 417-439
21. Julius M.H., Simpson E., and Herzenberg L.A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3 (1973) 645-649
22. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., and Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
23. Li P.F., Dietz R., and von Harsdorf R. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18 (1999) 6027-6036
24. Martelli A.M., Zweyer M., Ochs R.L., Tazzari P.L., Tabellini G., Narducci P., and Bortul R. Nuclear apoptotic changes: an overview. J. Cell. Biochem. 82 (2001) 634-646
25. Marzo I., Brenner C., Zamzami N., Susin S.A., Beutner G., Brdiczka D., Rémy R., Xie Z.H., Reed J.C., and Kroemer G. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J. Exp. Med. 187 (1998) 1261-1271
26. Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145 (1991) 185-192
27. McCright B., Rivers A., Audlin S., and Virshup D. The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J. Biol. Chem. 271 (1996) 22081-22089
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
29. Oliver C.J., and Shenolikar S. Physiologic importance of protein phosphatase inhibitors. Front. Biosci. 3 (1998) D961-D972
30. Pelicano H., Carney D., and Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist. Updat. 7 (2004) 97-110
31. Perticarari S., Presani G., Mangiarotti M.A., and Banfi E. Simultaneous flow cytometric method to measure phagocytosis and oxidative products by neutrophils. Cytometry 12 (1991) 687-693
32. Ryter S.W., Kim H.P., Hoetzel A., Park J.W., Nakahira K., Wang X., and Choi A.M. Mechanisms of cell death in oxidative stress. Antioxid. Redox Signal. 9 (2007) 49-89
33. Saydam G., Aydin H.H., Sahin F., Selvi N., Oktem G., Terzioglu E., Buyukkececi F., and Omay S.B. Involvement of protein phosphatase 2A in interferon-α-2b-induced apoptosis in K562 human chronic myelogenous leukaemia cells. Leuk. Res. 27 (2003) 709-717
34. Schönthal A.H. Role of serine/threonine protein phosphatase 2A in cancer. Cancer Lett. 170 (2001) 1-13
35. Simizu S., Tamura Y., and Osada H. Dephosphorylation of Bcl-2 by protein phosphatase 2A results in apoptosis resistance. Cancer Sci. 95 (2004) 266-270
36. Sontag E., Nunbhakdi-Craig V., Bloom G., and Mumby M. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J. Cell Biol. 128 (1995) 1131-1144
37. Sun X.M., Snowden R.T., Skilleter D.N., Dinsdale D., Ormerod M.G., and Cohen G.M. A flow cytometric method for the separation and quantitation of normal and apoptotic thymocytes. Anal. Biochem. 204 (1992) 351-356
38. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., and Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 (1999) 387-389
39. Suzuki S., Higuchi M., Proske R.J., Oridate N., Hong W.K., and Lotan R. Implication of mitochondria-derived reactive oxygen species, cytochrome c and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. Oncogene 18 (1999) 6380-6387
40. Tachibana Y., Scheuer P.J., Tsukitani Y., Kikuchi H., Van Engen D., Clardy J., Gopichand Y., and Schmitz F.J. Okadaic acid, a cytotoxic polyether from two marine sponges of the genus Halichondria. J. Am. Chem. Soc. 103 (1981) 2469-2471
41. Tada-Oikawa S., Oikawa S., Kawanishi M., Yamada M., and Kawanishi S. Generation of hydrogen peroxide precedes loss of mitochondrial membrane potential during DNA alkylation-induced apoptosis. FEBS Lett. 442 (1999) 65-69
42. Takeda K., Hatai T., Hamazaki T.S., Nishitoh H., Saitoh M., and Ichijo H. Apoptosis signal-regulating kinase 1 (ASK1) induces neuronal differentiation and survival of PC12 cells. J. Biol. Chem. 275 (2000) 9805-9813
43. Valko M., Rhodes C.J., Moncol J., Izakovic M., and Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160 (2006) 1-40
44. Van Hoof C., and Goris J. Phosphatases in apoptosis: to be or not to be, PP2A is in the heart of the question. Biochim. Biophys. Acta 1640 (2003) 97-104
45. Xin M., and Deng X. Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation. J. Biol. Chem. 281 (2006) 18859-18867
46. Yan W., Arai A., Aoki M., Ichijo H., and Miura O. ASK1 is activated by arsenic trioxide in leukemic cells through accumulation of reactive oxygen species and may play a negative role in induction of apoptosis. Biochem. Biophys. Res. Commun. 355 (2007) 1038-1044
47. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S.A., Petit P.S., Mignotte B., and Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182 (1995) 367-377